ODIN PAVES THE WAY FOR BETTER DRUG DEVELOPMENT WITH OPEN INNOVATION IN SCIENCE

With 54,5 M DKK from the Novo Nordisk Foundation (Grant number NNF20SA0061466), we will establish a network of academic and industrial researchers, who can co-create research projects that will help pave the way for better and more efficient drugs and diagnostics in the future.

We believe that many minds are better than one - and therefore we work hard to unite contributors across the university-industry divide. This will help us gain a better understanding of disease at the molecular level, which is essential to accelerate drug discovery.

Therefore, with a starting point in unmet patient needs, ODIN funds research projects about biomarkers and target validation.

Feel free to use our data under the CC NY license.